I upgrade from accumulte to BUY for a 19 share price Post the 2.27 conference call. My new price target for end of Q1 is 27.00 per share based upon the surge in revenue per the 980 high quantity infusion centers and record backlogs.
If you put in a gtc order it is filled allready at 13.66
keep in mind... 980 infusion centers. DR's Signing up in droves. NONE - no reimbursement issues. Proven solution. MFG in pLacePotentetial EU announcement Q1Potential M & A PLay
Anyone know if there are really backlogs ?Infusion centers have increased but any Press stating backlog info?Thanks
$5800 per full dose for Doctors too = money in the bank!All shorts are going to get SLAUGHTERED in 2012!